CRClaudia Ringhofer

Claudia Ringhofer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Claudia Ringhofer has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Waist to hip ratio is a better predictor of esophageal acid exposure than body mass index

    by C. Ringhofer, J. Lenglinger, M. Riegler, I. Kristo, A. Kainz, S. F. Schoppmann

    Background: Obesity and gastroesophageal reflux disease (GERD) are major health problems showing an inconstant relationship in the literature. Therefore, anthropometric parameters which are predictive and can simply be assessed at first patient presentation may lead to a better patient selection for ambulatory reflux monitoring. We aimed to examine the association of body mass index (BMI) and waist to hip ratio (WHR) with gastroesophageal reflux activity during 24 hour‐pH‐impedance monitoring.Methods: Seven hundred and seventy‐one patients with GERD symptoms underwent 24 hour‐pH‐impedance monitoring and high resolution manometry off proton pump inhibitors. Patients with known primary motility disorders of the esophagus and pre‐existing endoscopic or operative procedure on esophagus or stomach were excluded from the study. Reflux parameters and anthropometric and demographic data from our prospectively gathered database were analyzed. We performed univariate and multivariate regression analysis to evaluate the associations of BMI and WHR with reflux parameters measured with 24 hour‐pH‐impedance monitoring.Key Results: WHR showed a significantly stronger association with esophageal acid exposure than BMI (P<.001). Our data show that 6.9% of the percentage of endoluminal pHP=.05) and esophageal acid exposure.Conclusions and Inferences: WHR is a better predictor for esophageal acid exposure than BMI. Biomechanical and metabolic mechanisms of central fat distribution may influence reflux parameters in 24 hour pH impedance monitoring, which may affect patient selection for ambulatory reflux monitoring.


  • Quality of life after sympathetic surgery at the T4 ganglion for primary hyperhidrosis: Clip application versus diathermic cut

    by Peter Panhofer, Claudia Ringhofer, Andreas Gleiss, Raimund Jakesz, Manfred Prager, Georg Bischof, Christoph Neumayer

    Limited procedures at the T4 ganglion show low rates of compensatory sweating (CS). The aim of the study was to compare endoscopic sympathetic block (ESB) via clip application with endothoracic sympathicotomy (ETS) via diathermy with special regard on patients' quality of life (Qol). Treatment success, side effects and patient satisfaction were evaluated in a prospectively gathered database of a tertiary-care referral hospital. Two disease-specific Qol questionnaires were used (Keller, Milanez de Campos). 406 operations were performed in 205 patients (ESB4 N = 114, ETS4 N = 91) with a median follow-up of 12 months. Both procedures improved Qol significantly (P < 0.001) and the degree of improvement was equal in both groups. Palmar and axillary HH were ameliorated after both procedures (P < 0.001). Accordingly, plantar HH decreased after ESB4 (P = 0.002), while remaining unaltered after ETS4. Nineteen patients (9.3%) reported CS and 10 patients (4.9%) judged it as "disturbing". Nine of the latter belonged to the ETS4 group compared to one ESB patient (P = 0.015). Patients developed higher rates of plantar CS after ETS4 compared to ESB4 (P = 0.006). Five patients (2.4%) from both cohorts reported persistence of axillary HH. Recurrence of axillary symptoms was found in 5 ESB4 patients. Satisfaction rates did not differ significantly. Patients' Qol and satisfaction rates are similar in both treatment groups for upper limb HH. Outcome and recurrence rates speak in the favor of ETS4, severity of CS and potential reversibility argue for ESB4.


  • Gender Differences in Results of Reflux Monitoring Studies in Patients With Symptomatic GERD

    by Johannes Lenglinger, Margit Eisler, Claudia Ringhofer, Martin Riegler

  • W1899 Use of a Multichannel Intraluminal Impedance- and pH-Monitoring System to Assess Esophageal Transport Function

    by Johannes Lenglinger, Martina Seifert, Margit Eisler, Claudia Ringhofer, Johannes Zacherl, Gerhard Prager, Martin Riegler

  • Histopathology of columnar-lined esophagus in patients with gastroesophageal reflux disease

    by Johannes Lenglinger, Claudia Ringhofer, Margit Eisler, Roland Sedivy, Fritz Wrba, Johannes Zacherl, Enrico P. Cosentini, Gerhard Prager, Michael Haefner, Martin Riegler

    The question of whether an endoscopically normal-appearing esophagogastric junction should be biopsied in patients with gastroesophageal reflux disease is controversial. We have addressed this issue using endoscopy and histopathology.A total of 114 consecutive patients (58 males) with symptoms of gastroesophageal reflux disease prospectively underwent endoscopy, including biopsy sampling from the esophagogastric junction. Endoscopically visible columnar-lined esophagus was defined by the presence of gastric-type mucosa above the level of the rise of the gastric folds. Histopathology was conducted using the Paull-Chandrasoma classification.Of the 114 patients, 85 (74.6%) had endoscopically visible columnar-lined esophagus of length < or =0.5 cm (n = 82), 1 cm (n = 2) and 7 cm (n = 1); 29 patients (25.4%) had a normal endoscopic junction. All patients had histopathologic columnar-lined esophagus. Intestinal metaplasia and low-grade dysplasia was identified in 26 (22.8%) and 5 (4.4%) individuals, respectively, and was not statistically different in endoscopically normal vs. abnormal junction (P = 0.408 for intestinal metaplasia, P = 0.775 for low grade dysplasia). Intestinal metaplasia was independent from endoscopic esophagitis (P = 0.398) and hiatal hernia (P = 0.405).Columnar-lined esophagus cannot be excluded by endoscopy. In patients with gastroesophageal reflux disease, biopsy sampling of normal-appearing junction is recommended for histopathologic exclusion of intestinal metaplasia and low-grade dysplasia.


  • Videoendoscopy and histopathology of the esophagogastric junction in patients with gastroesophageal reflux disease

    by Claudia Ringhofer, Johannes Lenglinger, Margit Eisler, Fritz Wrba, Roland Sedivy, Johannes Zacherl, Enrico P. Cosentini, Gerhard Prager, Elena Devyatko, Martin Riegler

    HINTERGRUND: In der Endoskopie beginnt der Magen mit den sogenannten gastralen Schleimhautfalten. Anatomische Studien lassen jedoch vermuten, dass diese Falten zum Ösophagus gehören. Deshalb hat diese Studie die Histologie des Beginns der endoskopisch sichtbaren Magenfalten bei Patienten mit gastroösophagealer Refluxkrankheit untersucht. METHODIK: Bei 35 Patienten (20 Männern und 15 Frauen) mit gastroösophagealer Refluxkrankheit wurden Videoendoskopie und Biopsien aus dem ösophagogastralen Übergang durchgeführt. Endoskopie und Biopsien wurden digital aufgezeichnet. Zylinderepithelösophagus und Ösophagitis wurden entsprechend der Paull-Chandrasoma bzw. Los Angeles Klassifikation beurteilt. ERGEBNISSE: Endoskopie: Ein endoskopisch normaler ösophagogastraler Übergang und ein endoskopisch sichtbarer Zylinderepithelösophagus < 0,5 cm fanden sich bei 11 (31%) bzw. 24 (69%) Patienten. Histologie: Bei 22,8% und 51,4% der Patienten war der Zylinderepithelösophagus in Biopsien 1,0 cm bzw. 0,5 cm distal des Beginns der endoskopischen Magenfalten nachzuweisen. Bei 8 Patienten (22,9%) fand sich eine intestinale Metaplasie (= Barrett Ösophagus). ZUSAMMENFASSUNG: Endoskopisch kann ein histologischer Zylinderepithelösophagus in den so genannten Magenfalten nicht ausgeschlossen werden. Der Beginn der Magenfalten dient als Referenz-Ebene für die Biopsielokalisationen. BACKGROUND AND AIMS: During endoscopy the stomach is considered to rise at the level of the 'gastric' folds; however, anatomical studies have demonstrated that the proximal gastric folds may in fact be esophageal. This prospective study was designed to assess the histopathology of endoscopically visible proximal gastric folds in patients with gastroesophageal reflux disease. METHODS: 35 consecutive patients (20 males) with gastroesophageal reflux disease underwent video endoscopy, including biopsy sampling from the endoscopically visible esophagogastric junction (0 cm, 0.5 cm and 1.0 cm distal to the rise of gastric folds and 0.5 cm and 1.0 cm proximal to it). Endoscopy was digitally recorded and reviewed for assignment of biopsy level. Columnar-lined esophagus and esophagitis were cataloged according to the Paull-Chandrasoma histopathologic classification and the Los Angeles endoscopic classification. RESULTS: Endoscopy: Normal endoscopic esophagogastric junction was seen in 11 (31%) patients and visible columnar-lined esophagus ≤ 0.5 cm in 24 (69%). Histology: Columnar-lined esophagus extended 1.0 cm in 22.8% of patients and 0.5 cm in 51.4%, distal to the rise of the gastric folds. In all patients columnar-lined esophagus was interposed between squamous epithelium and gastric oxyntic mucosa. Thus, so-called gastric folds contained mucosa of esophageal origin in all patients. Intestinal metaplasia (Barrett esophagus) was detected in eight (22.9%) patients. CONCLUSIONS: Endoscopy cannot exclude histopathologic columnar-lined esophagus within gastric rugae. Thus, visible 'gastric' folds should not be used for definition of the esophagogastric junction but as a reference landmark for biopsy sampling during endoscopy.


    • 1 January 2007
      • Vol. 102  (1) , 206

    What about endoscopic invisible Barrett's esophagus?

    by Johannes Lenglinger, Claudia Ringhofer, Martin Riegler

  • Diagnosis of Gastroesophageal Reflux Disease (GERD)

    by Johannes Lenglinger, Claudia Ringhofer, Margit Eisler, Elena Devyatko, Enrico Cosentini, Fritz Wrba, Johannes Zacherl, Martin Riegler